Air Pollution Causes Rise in Babies Admitted to Intensive Care
When a woman is exposed to high levels of air pollution in the week before she gives birth, the baby is more likely to be admitted to a newborn intensive care unit, according to…
When a woman is exposed to high levels of air pollution in the week before she gives birth, the baby is more likely to be admitted to a newborn intensive care unit, according to…
It has long been observed that marijuana — or cannabis, weed, grass, or pot, as you prefer — can produce seemingly contradictory psychological effects in the people who smoke (or, these days, vape or…
The American dream is alive and well — at least for most of us — according to a new Gallup poll. Some 70% of those polled said that they consider the American dream to…
"Inaccurate or delayed diagnoses are the most catastrophic and costly of medical errors and will affect most of us in our lifetimes." So says the Society to Improve Diagnosis in Medicine.
While this company is unknown by many investors, one analyst believes that this could be even better than a double-your-money call.
UnitedHealth reported its second-quarter financial results before the markets opened on Thursday.
This weekend will be a real scorcher in two-thirds of the United States. Some cities have already set up cooling stations to prevent serious consequences, including heat stroke and heat exhaustion.
A major heat wave will hit two-thirds of the United States this weekend and may come with potentially very serious consequences, including heat stroke and heat exhaustion.
Johnson & Johnson shares took a hit after earnings, but it was more than just the earnings and guidance to blame. Some rivals may have been winning at the company's expense.
AvroBio shares continued their run on Wednesday, despite the firm announcing that it would be conducting a secondary offering.
Inovio Pharma shares dipped on Wednesday after the company said that it was taking measures to cut costs and its overall burn rate. When a company says it’s cutting costs one thing it can…
Johnson & Johnson shares traded lower despite beating earnings. It turns out that there are some issues outside of earnings that shareholders are having a hard time quantifying.
24/7 Wall St. has picked a few biotech standouts from Tuesday to highlight. We have included information about each company, as well as recent trading activity and the consensus analyst price target.
Johnson & Johnson retreated though it reported better than expected second-quarter before the markets opened on Tuesday.
Gilead and Galapagos each saw shares shoot up on Monday after the companies announced a new collaboration.